Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Creative Commons License

Fauser B. C. J. M., Tarlatzis B. C., Rebar R. W., Legro R. S., Balen A. H., Lobo R., ...More

FERTILITY AND STERILITY, vol.97, no.1, pp.28-63, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 97 Issue: 1
  • Publication Date: 2012
  • Doi Number: 10.1016/j.fertnstert.2011.09.024
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.28-63
  • Keywords: Polycystic ovary syndrome, hirsutism, contraception, pregnancy complications, quality of life, insulin resistance, type 2 diabetes, metabolic syndrome, cardiovascular disease, cancer, QUALITY-OF-LIFE, IMPAIRED GLUCOSE-TOLERANCE, ANTI-MULLERIAN HORMONE, BODY-MASS INDEX, CORONARY-ARTERY-DISEASE, STATES CASE-CONTROL, TERM-FOLLOW-UP, PREMATURE CAROTID ATHEROSCLEROSIS, OLIGOMENORRHEA AND/OR HIRSUTISM, CLOMIPHENE CITRATE INDUCTION
  • Hacettepe University Affiliated: Yes


Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with a high prevalence. The etiology of this heterogeneous condition remains obscure, and its phenotype expression varies. Two widely cited previous ESHRE/ASRMsponsored PCOS consensus workshops focused on diagnosis (published in 2004) and infertility management (published in 2008), respectively. The present third PCOS consensus report summarizes current knowledge and identifies knowledge gaps regarding various women's health aspects of PCOS. Relevant topics addressed-all dealt with in a systematic fashion-include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health, and finally cancer risk. Additional, comprehensive background information is provided separately in an extended online publication. (Fertil Steril (R) 2012;97:28-38. (C) 2012 by American Society for Reproductive Medicine.)